MedPath

Footwear for self-managing knee osteoarthritis symptoms: the Footstep Trial

Not Applicable
Completed
Conditions
Knee osteoarthritis
Musculoskeletal - Osteoarthritis
Registration Number
ACTRN12617001098325
Lead Sponsor
niversity of Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
164
Inclusion Criteria

i)aged greater than or equal to 50 years;
ii)report knee pain on most days of the past month;
iii)report a minimum pain score of 4 on an 11-point numeric rating scale during walking over the previous week;
iv)demonstrate tibiofemoral osteophytes on x-ray; and
v)demonstrate moderate-severe (Grade 3-4) tibiofemoral OA on x-ray as determined by the Kellgren & Lawrence grading system

Exclusion Criteria

i)Lateral joint space narrowing greater than or equal to medial joint space narrowing on x-ray;
ii)suffered knee pain for <3 months;
iii)recent knee surgery (past 6 months) or planned surgery in next 6 months;
iv)current use of shoe orthoses, customized shoes or ankle braces;
v)current primary use of high heels, thongs or work boots that would restrict ability to wear study shoes 6 hours/day;
vi)had a hip or knee replacement on either side;
vii)had a high tibial osteotomy on either leg;
viii)had any knee injections in the past 3 months or planned injections in next 6 months;
ix)self-report any other muscular, joint or neurological condition affecting lower limb function;
x)self-report any systemic or inflammatory joint disease (eg rheumatoid arthritis);
xi)current or planned use of a gait aid in the next 6 months
xii)inability to understand written/spoken English
xiii)unable to fulfill study requirements (eg wearing shoes, attending appointments, completing outcomes, do not have foot size in the range of 8 to 13US for men, and 7 to 12US for women).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath